Brenntag Shares Hover Near Critical 200-Day Line After Steep Month-Long Slide

Brenntag stock nears 200-day moving average after 12% monthly loss; Deutsche Bank downgrade and weak Q1 weigh. Key support at €52.50.

The bears have taken full control of Brenntag’s stock, with the chemicals distributor now testing a technical support level that could determine the next leg of its direction. Trading around €53.50 on Thursday, the shares have lost roughly 12% over the past month and sit just a whisker above the 200-day moving average, currently pegged at €52.63. A decisive break below that line would mark a fresh low for a stock that has already shed more than 16% from its 52-week peak of €63.76 set in May.

The selling pressure intensified after Deutsche Bank downgraded the stock from "Buy" to "Hold" and slashed its price target from €67 to €57, citing the risk that price and supply-chain advantages could unwind if geopolitical tensions ease. The note arrived just as the market was digesting a lackluster first-quarter update that revealed the depth of the volume challenge facing the company.

Revenue for the first three months of 2026 came in at €3.662 billion, down from €4.072 billion in the same period last year. Operating EBITDA fell 13.8% on a reported basis — and 8.3% in currency-adjusted terms — to €306 million. Cost savings of €27 million helped cushion the blow, but the headline numbers still disappointed. Free cash flow plunged from €163 million to €91 million, as higher prices tied to oil-linked chemicals and a rebuild of customer safety stocks tied up more working capital. On the positive side, the operating gross margin improved to 25.9% from 25.0%, suggesting the group retains some pricing power even as volumes sag.

Management has stood by its full-year guidance, targeting operating EBITDA between €1.15 billion and €1.35 billion for 2026. Yet the market appears skeptical the company can deliver on that range without the tailwind of higher prices and disrupted supply chains. The stock’s relative strength index now sits at 31.6, close to oversold territory but hardly a trigger for buyers. The 50-day moving average at €58.53 stands as a clear overhead resistance, while the average analyst price target of €54.81 suggests little upside from current levels.

The next major catalyst comes on August when Brenntag reports second-quarter figures. Until then, chartists will dominate the narrative. The stock already breached its 100-day moving average on June 15, and a sustained move below the 200-day line near €52.50 could accelerate the downturn. Management has scheduled a capital markets day for November 12, where it is expected to unveil a comprehensive strategy update that must convince investors that margin discipline and cost control can compensate for a normalising operating environment.